T Cell News and Research

Latest T Cell News and Research

Orange pigment may have potential as anti-cancer drug

An orange pigment found in lichens and rhubarb called parietin may have potential as an anti-cancer drug, scientists at Winship Cancer Institute of Emory University have discovered.

20 Oct 2015

Active nuclear deformations contribute to formation of intra-nuclear chromosome architectures

There are two types of chromatin, euchromatin and heterochromatin, that vary with the stages of the cell cycle. In particular, euchromatin with rich active genes localizes to the interior of the nucleus during interphase; heterochromatin usually localizes to the periphery of the nucleus.

20 Oct 2015

First primate model can help researchers to study mother-to-fetus CMV infections

Cytomegalovirus (CMV) is the leading infectious cause of birth defects worldwide, but scientists have been frustrated in their efforts to develop a vaccine to protect against infections.

20 Oct 2015

RUCDR Infinite Biologics awarded $6 million grant from NINDS

The National Institute of Neurological Disorders and Stroke has awarded a five-year grant worth up to $6,034,323 to RUCDR Infinite Biologics, a unit of Rutgers' Human Genetics Institute of New Jersey. RUCDR, which is located on Rutgers' Busch Campus in Piscataway, is the world's largest university-based biorepository.

20 Oct 2015

Stanford scientists identify a progenitor cell type that could repair damaged arteries

By tracking a single cell in a growing heart, scientists from Stanford University have discovered a cell type that could repair damaged arteries.

20 Oct 2015

New research seeks to improve understanding of how breast cancer starts

Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.

20 Oct 2015

First patients receive doses of antisense drug for Huntington's disease

The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.

20 Oct 2015

Discovery may lead to new anti-metastasis therapies for advanced-stage brain cancer patients

It's no surprise that people enjoy warm places like Hawaii but may suffer in hostile locales such as Antarctica. A tumor suppressor gene called PTEN is similar in that it is affected by the microenvironments of certain bodily organs to which it travels.

20 Oct 2015

Low levels of stem cell factor associated with increased risk of cardiovascular disease

New research indicates that low levels of a growth factor called stem cell factor (SCF)--which is thought to be important for blood vessel repair--are linked with an increased risk of cardiovascular disease.

20 Oct 2015

NAM announces election of three new members from UC San Diego School of Medicine

The National Academy of Medicine announced today the election of three new members from University of California, San Diego School of Medicine: Napoleone Ferrara, MD; Christopher K. Glass, MD, PhD; and Roberto Malinow, MD, PhD. Election to NAM is considered among the highest honors in the fields of health and medicine.

20 Oct 2015

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

Scientists at The Scripps Research Institute have found a way to change leukemia cells into leukemia-killing immune cells. The surprise finding could lead to a powerful new therapy for leukemia and possibly other cancers.

20 Oct 2015

New genetic discovery could lead to better treatment for X-linked diseases

Think back to middle school biology class, when you learned that boys have an X and a Y chromosome inside each cell, and girls have two X's.

20 Oct 2015

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that yesterday it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.

19 Oct 2015

Sequenom enters into clinical collaboration with CU School of Medicine

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with the University of Colorado Denver, School of Medicine.

19 Oct 2015

NCCN reveals new value initiative for CML and Multiple Myeloma

The National Comprehensive Cancer Network, a not-for-profit alliance of 26 of the world's leading cancer centers, today unveiled its new value initiative—the NCCN Evidence Blocks, published within new versions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Chronic Myelogenous Leukemia (CML) and Multiple Myeloma.

19 Oct 2015

Discovery may provide noninvasive approach to assessing toxic effects of anesthetic agents in children

Could looking at the eyes provide a new way of studying how anesthesia affects the developing brain? The retinas of immature mice exposed to one widely used general anesthetic show evidence of "programmed cell death," or apoptosis, reports a study in Anesthesia & Analgesia.

19 Oct 2015

Breakthrough advancements on new molecular mechanism may lead to Parkinson's treatments

More than one million people in the United States are afflicted with Parkinson's disease, a progressive disorder of the brain that affects movement and coordination. The cause is typically unknown, and presently there is no cure for the disease.

19 Oct 2015

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

Immatics US, Inc., a subsidiary of Immatics Biotechnologies GmbH, and The University of Texas Health Science Center at Houston will collaborate on cellular manufacturing for adoptive cellular therapy (ACT) clinical trials.

19 Oct 2015

UB study sheds light on the root causes of Huntington's disease

We've known for years that the Huntingtin protein (Htt) is responsible for Huntington's disease, a neurodegenerative disorder that diminishes a person's mental and physical abilities.

19 Oct 2015

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

Identifying a patient's genetic mutation led University of Arkansas for Medical Sciences (UAMS) physician-researcher Ling Gao, M.D., Ph.D., to an existing drug that eliminated the patient's stage IV Merkel-cell carcinoma. Gao's findings, made in collaboration with two other UAMS researchers, were published today in The New England Journal of Medicine.

19 Oct 2015

T Cell News and Research

Latest T Cell News and Research

Orange pigment may have potential as anti-cancer drug

Active nuclear deformations contribute to formation of intra-nuclear chromosome architectures

First primate model can help researchers to study mother-to-fetus CMV infections

RUCDR Infinite Biologics awarded $6 million grant from NINDS

Stanford scientists identify a progenitor cell type that could repair damaged arteries

New research seeks to improve understanding of how breast cancer starts

First patients receive doses of antisense drug for Huntington's disease

Discovery may lead to new anti-metastasis therapies for advanced-stage brain cancer patients

Low levels of stem cell factor associated with increased risk of cardiovascular disease

NAM announces election of three new members from UC San Diego School of Medicine

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

New genetic discovery could lead to better treatment for X-linked diseases

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

Sequenom enters into clinical collaboration with CU School of Medicine

NCCN reveals new value initiative for CML and Multiple Myeloma

Discovery may provide noninvasive approach to assessing toxic effects of anesthetic agents in children

Breakthrough advancements on new molecular mechanism may lead to Parkinson's treatments

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

UB study sheds light on the root causes of Huntington's disease

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in